Sjögren's and plasma cell variant Castleman disease: a case report

dc.contributor.authorDei-Adomakoh, Y.A.
dc.contributor.authorQuarcoopome, L.
dc.contributor.authorAbrahams, A.D.
dc.contributor.authorSegbefia, C.I.
dc.contributor.authorDey, D.I.
dc.date.accessioned2019-07-10T10:50:30Z
dc.date.available2019-07-10T10:50:30Z
dc.date.issued2018-04
dc.description.abstractCastleman disease is a rare cause of lymphoid hyperplasia and may result in localized symptoms or an aggressive, multisystem disorder. It can mimic other diseases like lymphoma or tuberculosis. It classically presents as a mediastinal mass that involves the lymphatic tissue primarily but can also affect extra lymphatic sites including the lungs, larynx, parotid glands, pancreas, meninges, and muscles. In HIV and HHV8-negative patients with idiopathic multi-centric Castleman disease, pathogenesis may involve autoimmune mechanisms. We highlight and report a case of a 34-year-old Ghanaian female who was successfully diagnosed and managed for Sjögren's as well as plasma cell variant Castleman disease with combination chemotherapy and rituximab followed by eighteen months maintenance therapy with pulse chlorambucil and prednisolone and three monthly rituximab.en_US
dc.identifier.otherDOI: 10.4314/gmj.v52i1.9
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/31349
dc.language.isoenen_US
dc.publisherGhana medical journalen_US
dc.subjectLymphadenopathyen_US
dc.subjectChemotherapyen_US
dc.subjectRituximaben_US
dc.subjectPlasma Cell Variant Castleman Diseaseen_US
dc.subjectSjögren's syndromeen_US
dc.titleSjögren's and plasma cell variant Castleman disease: a case reporten_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sjögren's and plasma cell variant Castleman disease a case report.pdf
Size:
189.28 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: